Latest filing published 19 Oct 2026 for Iambic Therapeutics, Inc..
Insider track record
No signal scores available.
Catalio Capital Management, LP: trading record in brief
Catalio Capital Management, LP is a declared insider of Iambic Therapeutics, Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 16 October 2026, with 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 19 October 2026 with a transaction in Iambic Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Catalio Capital Management, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,995,749 sharesCommon StockSEC:0001958125-26-000011:0
- 1,458,290 sharesCommon StockSEC:0001958125-26-000011:1
- 742,546 sharesCommon StockSEC:0001958125-26-000011:2
3 of 3 declarations